Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 3
Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,439 | Dovepress* | 6,439+ | 1,579 | 8,018 | |
| Totals | 6,439 | 1,579 | 8,018 | ||
|
*Since 15 July 2007 +Since July 2016 |
|||||
View citations on Google Scholar